- Home
- CRDF vs SRFM Comparison
CRDF vs SRFM Comparison
Compare CRDF & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- SRFM
- Stock Information
- Founded
- CRDF 1999
- SRFM 2011
- Country
- CRDF United States
- SRFM United States
- Employees
- CRDF N/A
- SRFM 634
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- SRFM Transportation Services
- Sector
- CRDF Health Care
- SRFM Consumer Discretionary
- Exchange
- CRDF Nasdaq
- SRFM Nasdaq
- Market Cap
- CRDF 152.3M
- SRFM 153.7M
- IPO Year
- CRDF N/A
- SRFM 2023
- Fundamental
- Price
- CRDF $2.15
- SRFM $2.69
- Analyst Decision
- CRDF Strong Buy
- SRFM Buy
- Analyst Count
- CRDF 4
- SRFM 4
- Target Price
- CRDF $10.63
- SRFM $5.75
- AVG Volume (30 Days)
- CRDF 723.0K
- SRFM 2.5M
- Earning Date
- CRDF 11-06-2025
- SRFM 11-12-2025
- Dividend Yield
- CRDF N/A
- SRFM N/A
- EPS Growth
- CRDF N/A
- SRFM N/A
- EPS
- CRDF N/A
- SRFM N/A
- Revenue
- CRDF $501,000.00
- SRFM $107,372,000.00
- Revenue This Year
- CRDF N/A
- SRFM N/A
- Revenue Next Year
- CRDF N/A
- SRFM $18.06
- P/E Ratio
- CRDF N/A
- SRFM N/A
- Revenue Growth
- CRDF N/A
- SRFM N/A
- 52 Week Low
- CRDF $1.90
- SRFM $1.50
- 52 Week High
- CRDF $5.64
- SRFM $9.91
- Technical
- Relative Strength Index (RSI)
- CRDF 43.50
- SRFM 25.32
- Support Level
- CRDF $2.06
- SRFM $3.04
- Resistance Level
- CRDF $2.33
- SRFM $3.73
- Average True Range (ATR)
- CRDF 0.11
- SRFM 0.28
- MACD
- CRDF -0.01
- SRFM -0.12
- Stochastic Oscillator
- CRDF 25.00
- SRFM 4.56
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.